Evoke Pharma Inc (EVOK)
4.35
-0.15
(-3.33%)
USD |
NASDAQ |
Nov 22, 16:00
4.22
-0.13
(-2.99%)
After-Hours: 20:00
Evoke Pharma Shareholders Equity (Quarterly): 4.387M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.387M |
| June 30, 2024 | 2.665M |
| March 31, 2024 | 3.497M |
| December 31, 2023 | -2.580M |
| September 30, 2023 | -0.8738M |
| June 30, 2023 | 0.5384M |
| March 31, 2023 | 2.126M |
| December 31, 2022 | 4.085M |
| September 30, 2022 | 5.533M |
| June 30, 2022 | 7.191M |
| March 31, 2022 | 1.934M |
| December 31, 2021 | 3.555M |
| September 30, 2021 | 4.773M |
| June 30, 2021 | 5.966M |
| March 31, 2021 | 7.811M |
| December 31, 2020 | -3.215M |
| September 30, 2020 | -1.923M |
| June 30, 2020 | -0.3737M |
| March 31, 2020 | 2.922M |
| December 31, 2019 | 4.380M |
| September 30, 2019 | 5.173M |
| June 30, 2019 | 6.346M |
| March 31, 2019 | 3.075M |
| December 31, 2018 | 4.025M |
| Date | Value |
|---|---|
| September 30, 2018 | 5.408M |
| June 30, 2018 | 5.360M |
| March 31, 2018 | 4.389M |
| December 31, 2017 | 2.166M |
| September 30, 2017 | 2.060M |
| June 30, 2017 | 6.77M |
| March 31, 2017 | 7.934M |
| December 31, 2016 | 3.788M |
| September 30, 2016 | 4.703M |
| June 30, 2016 | -1.527M |
| March 31, 2016 | 0.7572M |
| December 31, 2015 | 3.465M |
| September 30, 2015 | 5.308M |
| June 30, 2015 | 4.312M |
| March 31, 2015 | 6.433M |
| December 31, 2014 | 9.189M |
| September 30, 2014 | 11.69M |
| June 30, 2014 | 15.17M |
| March 31, 2014 | 18.45M |
| December 31, 2013 | 21.18M |
| September 30, 2013 | 19.22M |
| June 30, 2013 | -1.936M |
| March 31, 2013 | -1.696M |
| December 31, 2012 | -19.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-3.215M
Minimum
Dec 2020
7.811M
Maximum
Mar 2021
2.620M
Average
3.209M
Median
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp | 2.017B |
| Eli Lilly and Co | 14.24B |
| MEI Pharma Inc | 24.88M |
| Revance Therapeutics Inc | -163.03M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.15M |
| Total Liabilities (Quarterly) | 9.766M |
| Debt to Equity Ratio | 1.140 |
| Current Ratio | 1.437 |